Literature DB >> 29330301

Genetic control of predominantly error-free replication through an acrolein-derived minor-groove DNA adduct.

Jung-Hoon Yoon1, Richard P Hodge2, Linda C Hackfeld2, Jeseong Park1, Jayati Roy Choudhury1, Satya Prakash1, Louise Prakash3.   

Abstract

Acrolein, an α,β-unsaturated aldehyde, is generated in vivo as the end product of lipid peroxidation and from metabolic oxidation of polyamines, and it is a ubiquitous environmental pollutant. The reaction of acrolein with the N2 of guanine in DNA leads to the formation of γ-hydroxy-1-N2-propano-2' deoxyguanosine (γ-HOPdG), which can exist in DNA in a ring-closed or a ring-opened form. Here, we identified the translesion synthesis (TLS) DNA polymerases (Pols) that conduct replication through the permanently ring-opened reduced form of γ-HOPdG ((r) γ-HOPdG) and show that replication through this adduct is mediated via Rev1/Polη-, Polι/Polκ-, and Polθ-dependent pathways, respectively. Based on biochemical and structural studies, we propose a role for Rev1 and Polι in inserting a nucleotide (nt) opposite the adduct and for Pols η and κ in extending synthesis from the inserted nt in the respective TLS pathway. Based on genetic analyses and biochemical studies with Polθ, we infer a role for Polθ at both the nt insertion and extension steps of TLS. Whereas purified Rev1 and Polθ primarily incorporate a C opposite (r) γ-HOPdG, Polι incorporates a C or a T opposite the adduct; nevertheless, TLS mediated by the Polι-dependent pathway as well as by other pathways occurs in a predominantly error-free manner in human cells. We discuss the implications of these observations for the mechanisms that could affect the efficiency and fidelity of TLS Pols.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  (r) gamma-HOPdG phosphoramidite synthesis; DNA damage; DNA damage response; DNA polymerase; DNA repair; DNA replication; gamma-HOPdG; translesion synthesis in human cells

Mesh:

Substances:

Year:  2018        PMID: 29330301      PMCID: PMC5827445          DOI: 10.1074/jbc.RA117.000962

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  NMR characterization of a DNA duplex containing the major acrolein-derived deoxyguanosine adduct gamma -OH-1,-N2-propano-2'-deoxyguanosine.

Authors:  C de los Santos; T Zaliznyak; F Johnson
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

2.  Human DNA polymerase kappa encircles DNA: implications for mismatch extension and lesion bypass.

Authors:  Samer Lone; Sharon A Townson; Sacha N Uljon; Robert E Johnson; Amrita Brahma; Deepak T Nair; Satya Prakash; Louise Prakash; Aneel K Aggarwal
Journal:  Mol Cell       Date:  2007-02-23       Impact factor: 17.970

3.  Protein-template-directed synthesis across an acrolein-derived DNA adduct by yeast Rev1 DNA polymerase.

Authors:  Deepak T Nair; Robert E Johnson; Louise Prakash; Satya Prakash; Aneel K Aggarwal
Journal:  Structure       Date:  2008-02       Impact factor: 5.006

4.  Targeting of human DNA polymerase iota to the replication machinery via interaction with PCNA.

Authors:  L Haracska; R E Johnson; I Unk; B B Phillips; J Hurwitz; L Prakash; S Prakash
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

5.  Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts.

Authors:  F L Chung; H J Chen; R G Nath
Journal:  Carcinogenesis       Date:  1996-10       Impact factor: 4.944

6.  poliota, a remarkably error-prone human DNA polymerase.

Authors:  A Tissier; J P McDonald; E G Frank; R Woodgate
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

7.  Yeast Rev1 protein is a G template-specific DNA polymerase.

Authors:  Lajos Haracska; Satya Prakash; Louise Prakash
Journal:  J Biol Chem       Date:  2002-02-15       Impact factor: 5.157

8.  An incoming nucleotide imposes an anti to syn conformational change on the templating purine in the human DNA polymerase-iota active site.

Authors:  Deepak T Nair; Robert E Johnson; Louise Prakash; Satya Prakash; Aneel K Aggarwal
Journal:  Structure       Date:  2006-04       Impact factor: 5.006

9.  Highly error-free role of DNA polymerase eta in the replicative bypass of UV-induced pyrimidine dimers in mouse and human cells.

Authors:  Jung-Hoon Yoon; Louise Prakash; Satya Prakash
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

10.  Rev1 promotes replication through UV lesions in conjunction with DNA polymerases η, ι, and κ but not DNA polymerase ζ.

Authors:  Jung-Hoon Yoon; Jeseong Park; Juan Conde; Maki Wakamiya; Louise Prakash; Satya Prakash
Journal:  Genes Dev       Date:  2015-12-15       Impact factor: 11.361

View more
  5 in total

1.  Genetic evidence for reconfiguration of DNA polymerase θ active site for error-free translesion synthesis in human cells.

Authors:  Jung-Hoon Yoon; Robert E Johnson; Louise Prakash; Satya Prakash
Journal:  J Biol Chem       Date:  2020-03-13       Impact factor: 5.157

2.  Translesion synthesis DNA polymerases η, ι, and ν promote mutagenic replication through the anticancer nucleoside cytarabine.

Authors:  Jung-Hoon Yoon; Jayati Roy Choudhury; Louise Prakash; Satya Prakash
Journal:  J Biol Chem       Date:  2019-11-04       Impact factor: 5.157

3.  A novel role of DNA polymerase λ in translesion synthesis in conjunction with DNA polymerase ζ.

Authors:  Jung-Hoon Yoon; Debashree Basu; Karthi Sellamuthu; Robert E Johnson; Satya Prakash; Louise Prakash
Journal:  Life Sci Alliance       Date:  2021-01-29

4.  TEB/POLQ plays dual roles in protecting Arabidopsis from NO-induced DNA damage.

Authors:  Qiang Lv; Shuang Han; Lei Wang; Jinchan Xia; Peng Li; Ruoyang Hu; Jinzheng Wang; Lei Gao; Yuli Chen; Yu Wang; Jing Du; Fang Bao; Yong Hu; Xingzhi Xu; Wei Xiao; Yikun He
Journal:  Nucleic Acids Res       Date:  2022-06-23       Impact factor: 19.160

5.  Implications of inhibition of Rev1 interaction with Y family DNA polymerases for cisplatin chemotherapy.

Authors:  Jung-Hoon Yoon; Robert E Johnson; Louise Prakash; Satya Prakash
Journal:  Genes Dev       Date:  2021-08-12       Impact factor: 11.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.